Revium Rx. (RVRC) stock: key figures, P/E, revenue and dividend
Health Care · United States
Revium Rx. financials
| Fiscal year | 2025 |
|---|---|
| EBIT | -13.09 m USD |
| Net income | -13.45 m USD |
| Diluted EPS – continuing operations | -0.22 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Revium Rx.
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors; specializes in infectious diseases, including antibiotic-resistant infections, solid tumors, and vaccination; and develops nano-liposomal particles (NLP) based pharmaceutical candidates. It also offers Nano-Mupirocin, a NLP-based formulation of potent antibiotic mupirocin. In addition, the company develops nanoparticles-based formulation of an angiotensin receptor blockers; novel adjunct for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx. was incorporated in 1997 and is headquartered in Herzliya, Israel.
More stocks
- Rithm Property Trust Inc. (RPT)
- Tricorntech Corporation (6909.TW)
- G-Able PCL (GABLE.BK)
- Patrangsit Healthcare Group Public Company Limited (PHG.BK)
- Luda Technology Group Limited (LUD)
- Leofoo Development Co Ltd (2705.TW)
- Seritage Growth Properties (SRG)
- Shihlin Development Company Limited (5324.TWO)
- Hites S.A. (HITES.SN)
- Here Group Limited (HERE)
- Tropical Canning (Thailand) Public Company Limited (TC.BK)
- Kumkang Kind (014280.KS)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.